Suven Pharmaceuticals (SUVENPHAR.NSE) Q2 2025 Earnings

28MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
2.12
2.58
3.04
3.5

Details

Expected EPS
3.3972317261200002
Actual EPS
3.4971503063000005
Surprise EPS
0.1
Surprise Percent
+2.94%

Description

Suven Pharmaceuticals (SUVENPHAR.NSE) has reported earnings of 3.4971503063000005 per share for Q2 2025.

0 Comments

Share your thoughts